Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Spatz

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
JCO Precision Oncology|January 20, 2022
Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical LaboratoriesNatasha B Leighl, Suzanne Kamel-Reid, Parneet K Cheema, et al.
Cell Reports. Medicine|April 16, 2025
Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting responseThierry Alcindor, James Tankel, Pierre-Olivier Fiset, et al.
Clinical Proteomics|February 15, 2020
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibitionMathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, et al.
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicineZuanel Diaz, Adriana Aguilar-Mahecha, Eric R Paquet, et al.
The Journal of Molecular Diagnostics : JMD|December 31, 2022
CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA SequencingTracy L Stockley, Bryan Lo, Adrian Box, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
JCO Precision Oncology|January 20, 2022
Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical LaboratoriesNatasha B Leighl, Suzanne Kamel-Reid, Parneet K Cheema, et al.
Cell Reports. Medicine|April 16, 2025
Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting responseThierry Alcindor, James Tankel, Pierre-Olivier Fiset, et al.
Clinical Proteomics|February 15, 2020
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibitionMathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, et al.
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicineZuanel Diaz, Adriana Aguilar-Mahecha, Eric R Paquet, et al.
The Journal of Molecular Diagnostics : JMD|December 31, 2022
CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA SequencingTracy L Stockley, Bryan Lo, Adrian Box, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Pageof 8